AI Article Synopsis
- - Pancreatic cancer is highly aggressive and deadly, with a five-year survival rate under 10%, indicating a critical need for better early diagnosis and targeted treatment options.
- - Although treatment advancements have been made, the overall prognosis for patients with pancreatic cancer is still very poor.
- - Recent research has improved our understanding of the molecular mechanisms involved in pancreatic cancer, leading to potential targets for diagnosis and treatment.
Article Abstract
Pancreatic cancer is one of the most aggressive and lethal forms of cancer, with a five-year survival rate of less than 10%. Despite advances in treatment modalities, the prognosis for pancreatic cancer patients remains poor, highlighting the urgent need for innovative approaches for early diagnosis and targeted therapies. In recent years, there has been significant progress in understanding the molecular mechanisms underlying pancreatic cancer development and progression. This paper reviews the current knowledge of molecular targets for the diagnosis and treatment of pancreatic cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476914 | PMC |
| http://dx.doi.org/10.3390/ijms251910843 | DOI Listing |
Publication Analysis
Top Keywords
pancreatic cancer
20
molecular targets
8
targets diagnosis
8
diagnosis treatment
8
treatment pancreatic
8
cancer
6
pancreatic
5
cancer pancreatic
4
cancer aggressive
4
aggressive lethal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!